Their preliminary findings suggested that for patients taking statins there was a highly significant reduction in the annual rate of CKD progression compared with control groups (based on the annual rate of change in eGFR).
← all excerpts
Effects of antihypertensives, lipid-modifying drugs, glycaemic control drugs and sodium bicarbonate on the progression of stages 3 and 4 chronic kidney disease in adults: a systematic review and meta-analysis.
1
—
—